Benzinga | Oct 21, 2021 12:11PM EDT

William Blair Initiates Coverage On Jasper Therapeutics with Outperform Rating

William Blair analyst Matt Phipps initiates coverage on Jasper Therapeutics (NASDAQ:JSPR) with a Outperform rating.